VITUZ Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vituz, and when can generic versions of Vituz launch?
Vituz is a drug marketed by Persion and is included in one NDA.
The generic ingredient in VITUZ is chlorpheniramine maleate; hydrocodone bitartrate. There are twenty-nine drug master file entries for this compound. Additional details are available on the chlorpheniramine maleate; hydrocodone bitartrate profile page.
Summary for VITUZ
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Patent Applications: | 24 |
Formulation / Manufacturing: | see details |
DailyMed Link: | VITUZ at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for VITUZ
US Patents and Regulatory Information for VITUZ
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Persion | VITUZ | chlorpheniramine maleate; hydrocodone bitartrate | SOLUTION;ORAL | 204307-001 | Feb 20, 2013 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |